The Uromigos

AZGUONC-PRODUCTIONwarmup

<p>Dr. Andrea Necchi describes the efficacy and toxicity of neoadjuvant sacituzumab govitecan in urothelial carcinoma from the new SURE1 trial.</p>


Dr. Andrea Necchi describes the efficacy and toxicity of neoadjuvant sacituzumab govitecan in urothelial carcinoma from the new SURE1 trial.